Acceder

Publicaciones - FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA

Cargando...
Gil Candel M, Gascon Canovas JJ, Urbieta Sanz E, Gomez Espin R, Nicolas de Prado I, Iniesta Navalon C. Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease. Rev Esp Enferm Dig. 2020 May;112(5):360-366. doi: 10.17235/reed.2020.6618/2019. PubMed PMID: 32338010.
AÑO: 2020; IF: 2.086
32338010
Gil-Candel M, Gascon-Canovas JJ, Urbieta-Sanz E, Rentero-Redondo L, Onteniente-Candela M, Iniesta-Navalon C. Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease. Int J Clin Pharm. 2020 Apr;42(2):500-507. doi: 10.1007/s11096-020-00978-6. Epub 2020 Jan 31. PubMed PMID: 32006141.
AÑO: 2020; IF: 2.054
32006141
Iniesta-Navalon C, Gascon-Canovas JJ, Gama ZADS, Sanchez-Ruiz JF, Gutierrez-Estrada EA, De-la-Cruz-Sanchez E, Harrington-Fernandez O. Potential and clinical relevant drug-drug interactions among elderly from nursing homes: a multicentre study in Murcia, Spain. Cien Saude Colet. 2019 May 30;24(5):1895-1902. doi: 10.1590/1413-81232018245.16032017. PubMed PMID: 31166522.
AÑO: 2019; IF: 1.019
31166522
Caballero Requejo C, Urbieta Sanz E, Iniesta Navalon C, Gascon Canovas JJ. [Incorporation of direct-acting oral anticoagulants to available therapeutic arsenal: Progress adequately?]. Aten Primaria. 2019 Mar;51(3):184-185. doi: 10.1016/j.aprim.2018.11.004. Epub 2019 Jan 17. No abstract available. Spanish. PubMed PMID: 30660438; PubMed Central PMCID: PMC6837083.
AÑO: 2019; IF: 1.087
30660438
Caballero-Requejo C, Monteagudo-González L, Urbieta-Sanz E. [Anaphylactic reaction by certolizumab in young woman with rheumatoid arthritis]. Farm Hosp. 2018 May 1;42(3):135-136. doi: 10.7399/fh.10914. Spanish. PubMed PMID: 29730985.
AÑO: 2018
29730985
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA